# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1908355 | 2 (tenidap) | inhibition | = | 2.63 | % | ALA4808150 | % | Homo sapiens | |||
2. | ALA1908355 | 2 (tenidap) | inhibition | = | -13.25 | % | ALA4808149 | % | Homo sapiens | |||
3. | ALA1908355 | 2 (tenidap) | Inhibition | = | 75.2 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
4. | ALA1908355 | 2 (tenidap) | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
5. | ALA1908355 | 2 (tenidap) | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
6. | ALA1908355 | 2 (tenidap) | inhibition | = | -0.18 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (mechanism) | 0 | ALA3137740 | |||||||
8. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (time to onset) | 0 | ALA3137739 | |||||||
9. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (comment) | 0 | ALA3137738 | |||||||
10. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (successful reintroduction) | 0 | ALA3137737 | |||||||
11. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (animal toxicity known) | 0 | ALA3137736 | |||||||
12. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (benign tumour) | = | 0 | ALA3137735 | references out of a total of 3 | |||||
13. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (malignant tumour) | = | 0 | ALA3137734 | references out of a total of 3 | |||||
14. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (steatosis) | = | 0 | ALA3137733 | references out of a total of 3 | |||||
15. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (association with vascular disease) | = | 0 | ALA3137732 | references out of a total of 3 | |||||
16. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (granulomatous hepatitis) | = | 0 | ALA3137731 | references out of a total of 3 | |||||
17. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (cirrhosis) | = | 0 | ALA3137730 | references out of a total of 3 | |||||
18. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (chronic liver disease) | = | 0 | ALA3137729 | references out of a total of 3 | |||||
19. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (severe hepatitis) | = | 0 | ALA3137728 | references out of a total of 3 | |||||
20. | ALA1908355 | 2 (tenidap) | Hepatotoxicity (choleostasis) | = | 1 | ALA3137727 | references out of a total of 3 |